Swiss-Prot entry
ID PPAR_XENLA STANDARD; PRT; 474 AA.
AC P37232;
DT 01-OCT-1994 (Rel. 30, Created)
DT 01-OCT-1994 (Rel. 30, Last sequence update)
DT 01-MAY-2005 (Rel. 47, Last annotation update)
DE Peroxisome proliferator activated receptor alpha (PPAR-alpha).
GN Name=PPARA; Synonyms=NR1C1;
OS Xenopus laevis (African clawed frog).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC Amphibia; Batrachia; Anura; Mesobatrachia; Pipoidea; Pipidae;
OC Xenopodinae; Xenopus; Xenopus.
OX NCBI_TaxID=8355;
RN [1]
RP NUCLEOTIDE SEQUENCE.
RX MEDLINE=92191267; PubMed=1312391 [NCBI, ExPASy, EBI, Israel, Japan]; DOI=10.1016/0092-8674(92)90031-7;
RA Dreyer C., Krey G., Keller H., Givel F., Helftenbein G., Wahli W.;
RT "Control of the peroxisomal beta-oxidation pathway by a novel family
RT of nuclear hormone receptors.";
RL Cell 68:879-887(1992).
RN [2]
RP CHARACTERIZATION.
RX MEDLINE=94100165; PubMed=8274443 [NCBI, ExPASy, EBI, Israel, Japan]; DOI=10.1016/0960-0760(93)90058-5;
RA Krey G., Keller H., Mahfoudi A., Medin J., Ozato K., Dreyer C.,
RA Wahli W.;
RT "Xenopus peroxisome proliferator activated receptors: genomic
RT organization, response element recognition, heterodimer formation with
RT retinoid X receptor and activation by fatty acids.";
RL J. Steroid Biochem. Mol. Biol. 47:65-73(1993).
CC -!- FUNCTION: Receptor that binds peroxisome proliferators such as
CC hypolipidemic drugs and fatty acids. Once activated by a ligand,
CC the receptor binds to a promoter element in the gene for acyl-CoA
CC oxidase and activates its transcription. It therefore controls the
CC peroxisomal beta-oxidation pathway of fatty acids.
CC -!- SUBUNIT: Heterodimer with the retinoid X receptor.
CC -!- SUBCELLULAR LOCATION: Nuclear.
CC -!- TISSUE SPECIFICITY: Ubiquitous.
CC -!- DEVELOPMENTAL STAGE: Oocytes, embryos, and adults.
CC -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR1
CC subfamily.
CC -!- SIMILARITY: Contains 1 nuclear receptor DNA-binding domain.
CC --------------------------------------------------------------------------
CC This Swiss-Prot entry is copyright. It is produced through a collaboration
CC between the Swiss Institute of Bioinformatics and the EMBL outstation -
CC the European Bioinformatics Institute. There are no restrictions on its
CC use as long as its content is in no way modified and this statement is not
CC removed.
CC --------------------------------------------------------------------------
DR EMBL; M84161; AAA49935.1; -. [EMBL / GenBank / DDBJ] [CoDingSequence]
DR PIR; A42214; A42214.
DR HSSP; Q07869; 1KKQ. [HSSP ENTRY / SWISS-3DIMAGE / PDB]
DR SMR; P37232; 209-474.
DR TRANSFAC; T01352; -.
DR InterPro; IPR000536; Hrmon_recept_lig.
DR InterPro; IPR001723; Stdhrmn_receptor.
DR InterPro; IPR008946; Str_ncl_receptor.
DR InterPro; IPR001628; Znf_C4steroid.
DR InterPro; Graphical view of domain structure.
DR Pfam; PF00104; Hormone_recep; 1.
DR Pfam; PF00105; zf-C4; 1.
DR Pfam; Graphical view of domain structure.
DR PRINTS; PR01288; PROXISOMEPAR.
DR PRINTS; PR01289; PROXISOMPAAR.
DR PRINTS; PR00398; STRDHORMONER.
DR PRINTS; PR00047; STROIDFINGER.
DR ProDom; PD000035; Znf_C4steroid; 1.
DR ProDom [Domain structure / List of seq. sharing at least 1 domain ]
DR SMART; SM00430; HOLI; 1.
DR SMART; SM00399; ZnF_C4; 1.
DR PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
DR HOVERGEN [Family / Alignment / Tree]
DR BLOCKS; P37232.
DR ProtoNet; P37232.
DR ProtoMap; P37232.
DR PRESAGE; P37232.
DR DIP; P37232.
DR ModBase; P37232.
DR SWISS-2DPAGE; GET REGION ON 2D PAGE.
KW Activator; DNA-binding; Multigene family; Nuclear protein; Receptor;
KW Transcription; Transcription regulation; Zinc-finger.
FT DNA_BIND 106 180 Nuclear receptor-type.
FT ZN_FING 109 129 C4-type.
FT ZN_FING 146 168 C4-type.
FT DOMAIN 287 474 Ligand-binding (Potential).
SQ SEQUENCE 474 AA; 52856 MW; 4DBB941318D43483 CRC64;
MSTIMVDTNS ELCILTPLDE DDLESPLSGE FLQDIVDIQD ITQTIGDDGS TPFGASEHQF
FGNSPGSIGS VSTDLTDTLS PASSPASITF PAASGSAEDA ACKSLNLECR VCSDKASGFH
YGVHACEGCK GFFRRTIRLK LVYDRCERMC KIQKKNRNKC QYCRFEKCLN VGMSHNAIRF
GRMPRSEKAK LKAEVLMCDQ DVKDSQMADL LSLARLIYDA YLKNFNMNKV KARAILTGKA
SNPPFVIHDM ETLCMAEKTL VAKLVANGIQ NKEAEVRIFH CCQCTSVETV TELTEFAKSI
PGFTELDLND QVTLLKYGVY EAMFAMLASV MNKDGMLVAY GNGFITREFL KSLRKPIGDM
MEPKFEFAMK FNALELDDSD LSLFVAALIC CGDRPGLVNI PSIEKMQESI VHVLKLHLQS
NHPDDSFLFP KLLQKMADLR QLVTEHAQLV QTIKKTETDA ALHPLLQEIY RDMY
//